Merrimack Pharma Cutting Jobs Again After Shelving Third Cancer Drug In Year

 
• By Sten Stovall
Crisis
MM-310's Failure Deepens Crisis At Merrimack Pharma • Source: Shutterstock

More from Clinical Trials

More from R&D